Manulife (Manufacturers Life Insurance)
ECYT

Manulife (Manufacturers Life Insurance)’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-41,975
Closed -$745K – 2926
2018
Q3 		$745K Sell
41,975
-6,501
-13% -$112K ﹤0.01% 1997
2018
Q2 		$669K Buy
48,476
+46,652
+2,558% +$554K ﹤0.01% 2165
2018
Q1 		$17K Buy
1,824
+23
+1% +$127 ﹤0.01% 3796
2017
Q4 		$8K Buy
+1,801
New +$8.58K ﹤0.01% 4052
2017
Q3 		– Sell
-990
Closed -$1K – 4428
2017
Q2 		$1K Sell
990
-106
-10% -$228 ﹤0.01% 4318
2017
Q1 		$3K Sell
1,096
-8,153
-88% -$18.9K ﹤0.01% 3915
2016
Q4 		$24K Buy
9,249
+7,753
+518% +$22.3K ﹤0.01% 3584
2016
Q3 		$4K Hold
1,496
– – ﹤0.01% 3973
2016
Q2 		$5K Sell
1,496
-26,751
-95% -$98K ﹤0.01% 3834
2016
Q1 		$94K Buy
28,247
+1,074
+4% +$3.51K ﹤0.01% 3077
2015
Q4 		$109 Hold
27,173
– – ﹤0.01% 3056
2015
Q3 		$124 Hold
27,173
– – ﹤0.01% 3021
2015
Q2 		$141 Buy
27,173
+552
+2% +$3.31K ﹤0.01% 3154
2015
Q1 		$167 Buy
26,621
+463
+2% +$2.67K ﹤0.01% 2878
2014
Q4 		$164 Buy
26,158
+1,438
+6% +$8.77K ﹤0.01% 2785
2014
Q3 		$150 Buy
24,720
+578
+2% +$3.95K ﹤0.01% 2833
2014
Q2 		$159K Buy
24,142
+630
+3% +$7.1K ﹤0.01% 2898
2014
Q1 		$560 Sell
23,512
-105
-0.4% -$1.52K ﹤0.01% 2005
2013
Q4 		$253 Sell
23,617
-807
-3% -$8.91K ﹤0.01% 2542
2013
Q3 		$326 Sell
24,424
-1,065
-4% -$16.8K ﹤0.01% 2273
2013
Q2 		$335K Buy
+25,489
New +$344K ﹤0.01% 2159

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ECYT Position: Q4 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 41,975 shares — an estimated $745K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ECYT in Q2 2013 and held it in 21 quarters. The position peaked at $745K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 41,975 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $745K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 21 quarters.
  • Manulife (Manufacturers Life Insurance)'s Endocyte, Inc. Common Stock position peaked at $745K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2018, filed 14 Feb 2019.